Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced that the ...

The United States Insulin Pump Market is projected to grow from US$ 1.55 billion in 2024 to US$ 2.58 billion in 2033, with a ...

Tandem Diabetes Care, Inc. , a global insulin delivery and diabetes technology company, announced that the t:slim X2 insulin pump, featuring Control-IQ+ automated insulin delivery (AID) technology, is ...

Tandem Diabetes Care (Nasdaq:TNDM) today announced the rollout of its latest automated insulin delivery system integration.

Tandem Diabetes has announced that the t:slim X2 insulin pump, featuring Control-IQ+ automated insulin delivery (AID) technology, is now available with Abbott’s FreeStyle Libre 3 Plus ...

Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) fell 6% in the afternoon session after investor ...

Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.

Pivot continues to progress toward CE Mark certification in 2026Stage 1 ISO Audit completed with Stage 2 planned for 1H2026 SAN DIEGO, CA / ACCESS Newswire / October 28, 2025 / Modular Medical, Inc.

Pivot continues to progress toward CE Mark certification in 2026Stage 1 ISO Audit completed with Stage 2 planned for 1H2026 SAN DIEGO, CA / ACCESS Newswire / October 28, 2025 / Modular Medical ...

The market awaits DexCom's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter. It's important for new investors to u ...

Dexcom faces new FDA reports linking its G7 glucose monitor to patient deaths as lawsuits and regulatory scrutiny intensify.

Băi wén bù rú yī jiàn“Seeing for oneself is a hundred times better than hearing from others.”Chinese Proverb from the Book of ...